
Advos
Advos.io
@advos
16792 articles
Articles

Tailored Vitamin D Doses Reduce Heart Attack Risk by 52% in Heart Disease Patients
Adults with heart disease who received vitamin D doses tailored to achieve optimal blood levels reduced their risk of heart attack by 52% compared to those who did not have their vitamin D levels managed, according to preliminary research from the TARGET-D clinical trial. The findings, to be presented at the American Heart ...
November 9, 2025Read more

Daily Coffee Consumption May Reduce Atrial Fibrillation Recurrence in Some Patients, Study Finds
A new clinical trial presented at the American Heart Association's Scientific Sessions 2025 suggests that daily coffee consumption may significantly reduce the recurrence of atrial fibrillation in some adults, challenging long-held beliefs about caffeine's effects on heart rhythm disorders. The study found that AFib patient...
November 9, 2025Read more

Diabetes Drug Metformin Shows Promise in Reducing AFib Recurrence After Ablation in Overweight Patients
The diabetes medication metformin may help reduce recurrent atrial fibrillation episodes in overweight and obese patients who undergo catheter ablation procedures, according to preliminary research presented at the American Heart Association's Scientific Sessions 2025. The findings suggest that this widely available, low-co...
November 9, 2025Read more

Earlier Blood Transfusions May Reduce Heart Failure Risk in Cardiac Patients After Surgery
A new study presented at the American Heart Association's Scientific Sessions 2025 suggests that earlier blood transfusions may significantly reduce the risk of heart failure and irregular heartbeat in patients with heart disease undergoing major surgery. The Transfusion Trigger after Operations in High Cardiac Risk Patient...
November 8, 2025Read more

Catheter Ablation May Eliminate Need for Blood Thinners in AFib Patients, Study Finds
A minimally invasive heart procedure called catheter ablation may reduce stroke risk enough that some atrial fibrillation patients can safely discontinue blood thinners, according to new research presented at the American Heart Association's Scientific Sessions 2025. The findings from the OCEAN Randomized Trial suggest that...
November 8, 2025Read more

Study Finds Standard Medication Outperforms Heart Procedure for High-Risk Atrial Fibrillation Patients
Standard medical care including blood thinners proved more effective than a minimally invasive heart procedure for older patients with irregular heart rhythms who face high risks of stroke and bleeding, according to research presented at the American Heart Association's Scientific Sessions 2025. The findings challenge assum...
November 8, 2025Read more

Shorter Clot-Prevention Therapy After Stent Placement Shows Equal Effectiveness with Reduced Bleeding Risk in AFib Patients
Patients with atrial fibrillation who receive coronary stents may soon benefit from a shorter, safer medication regimen according to new research presented at the American Heart Association's Scientific Sessions 2025. The study found that a one-month course of dual clot-preventing therapy followed by single medication thera...
November 8, 2025Read more

Oral Cholesterol Medication Shows Promise as Alternative to Injectable Therapies
For individuals who have experienced heart attacks or strokes, or who face high cardiovascular risk, a new daily oral medication may provide an effective alternative to injectable cholesterol-lowering therapies. Research presented at the American Heart Association's Scientific Sessions 2025 indicates that the investigationa...
November 8, 2025Read more

PCSK9 Inhibitor Shows Significant Reduction in First Major Cardiovascular Events in High-Risk Patients
Adding the PCSK9 inhibitor evolocumab to high-intensity cholesterol-lowering regimens significantly reduces the risk of first major cardiovascular events in adults with atherosclerotic cardiovascular disease or diabetes, according to findings from the international VESALIUS-CV clinical trial presented at the American Heart ...
November 8, 2025Read more

CRISPR Gene-Editing Therapy Shows Promise in Reducing Cholesterol and Triglycerides in First Human Trial
In a Phase 1 clinical trial involving 15 participants, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) demonstrated significant reductions in LDL cholesterol and triglycerides with an acceptable safety profile. The therapy, called CTX310, reduced LDL cholesterol ...
November 8, 2025Read more

New Multi-Receptor Medication Shows Promise for Severe Triglyceride Reduction and Liver Health
An investigational medication called DR10624 reduced triglyceride levels by more than 60% in most patients with severe hypertriglyceridemia while also significantly decreasing liver fat, according to preliminary research presented at the American Heart Association's Scientific Sessions 2025. The findings suggest this first-...
November 8, 2025Read more

Milevista Partners with Operation Smile to Raise $6.7 Million for Cleft Surgery Access
Culver City-based experiential marketing agency Milevista has announced a strategic partnership with global medical nonprofit Operation Smile to raise $6.7 million by December 31, 2027. The collaboration will focus on supporting surgical care, comprehensive cleft treatment, and family-focused programs for children born with...
November 8, 2025Read more

TuneFab Transforms from Music Downloader to Comprehensive Management Platform
TuneFab has launched a significant update to its All-in-One Music Converter, fundamentally shifting the tool from a high-speed downloader to a comprehensive music management ecosystem. This transformation addresses the growing problem of music platform fragmentation, where users typically subscribe to multiple services like...
November 8, 2025Read more

White Paper Reveals Systemic Sanitation and Safety Failures at U.S. Airports
New York Airport News has published a comprehensive white paper titled "Systemic Sanitation and Environmental Failures at U.S. Airports" that reveals critical lapses in environmental and sanitation oversight across major American airports. The investigation was prompted by the November 5 UPS cargo plane crash at Louisville ...
November 8, 2025Read more

Yang Qian to Lead Cymatics Digital's 'My Life in LA' Short Film Production
Cymatics Digital LLC has announced that acclaimed producer Yang Qian will serve as Lead Producer for "My Life in LA," the company's upcoming short film project. This marks the sixth installment in Cymatics Digital's production slate and represents a significant commitment to collaborating with world-class talent in the film...
November 8, 2025Read more

Fifth Annual Sickle Cell Caregiver Summit Focuses on Mental Wellness and Legacy Building
The Sickle Cell Community Consortium (SC3), in collaboration with Cleverly Changing, LLC, The B Strong Group, and Discovering Moorer2Life, will host the Fifth Annual Sickle Cell Caregiver Summit virtually from November 13–16, 2025. This year's theme, "The Heart of Caregiving: Balancing Mental Wellness, Advocacy, and Legacy,...
November 8, 2025Read more

Yao Wen Appointed Production Designer for Scroll&Swoon's Vertical Series 'Carole's Regrets'
The appointment of production designer Yao Wen to Scroll&Swoon's upcoming vertical-format series Carole's Regrets represents a significant development in the evolution of digital storytelling for mobile audiences. As production designer, Wen will lead the visual design for the series scheduled for production from October 1,...
November 8, 2025Read more

Klaiyi Hair Launches Extended Black Friday Pre-Sale with Multi-Phase Discount Strategy
Klaiyi Hair has initiated its 2025 Black Friday pre-sale event, implementing a strategic two-phase discount approach that spans from November 6 through November 20. This extended promotional period represents a significant shift in retail timing, allowing consumers early access to holiday savings while providing the company...
November 8, 2025Read more

First Slice Production Taps Vedant Dave as Cinematographer for Immigrant Drama 'The Last Address'
First Slice Production LLC has announced Vedant Dave as director of photography for the upcoming feature film "The Last Address," a decision that underscores the production company's commitment to visual storytelling excellence in films exploring complex human experiences. The feature, directed and executive produced by Gur...
November 8, 2025Read more

TSC's AI Signal Copier Transforms Automated Trading with Advanced Intelligence
Telegram Signal Copier has been recognized as the leading AI signal copier in the trading community, introducing several unique features powered by sophisticated artificial intelligence systems. The platform's AI-driven functionalities address critical challenges faced by traders who monitor multiple signal channels, emphas...
November 8, 2025Read more

SureShotFX Recognized as Leading Forex Signal Provider with Global Trader Following
SureShotFX, a prominent foreign currency signal provider in the trading sector, has received official recognition as the leading provider in its field. The company's foundation built on accuracy, transparency, and consistent profitability is transforming how traders participate in the dynamic Forex trading environment.In to...
November 8, 2025Read more